Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong Showcases Latest Real-Time PCR System and Innovative Molecular Diagnostic Solutions at MEDICA 2023

By LabMedica International staff writers
Posted on 29 Nov 2023
TianLong Science and Technology Co., Ltd. More...
(Shaanxi, China) is showcasing its cutting-edge products and innovative molecular diagnostic solutions at MEDICA 2023.

MEDICA in Düsseldorf, a leading medical B2B trade fair, has once again become a global highlight from 13-16 November this year. Tianlong Technology made its appearance at this grand event, in collaboration with Kehua Bio-engineering, showcasing the latest IVD solutions to the global market.

TianLong participated in MEDICA 2023 with excellent products and solutions including iGeneCase 1600 Diagnostics-in-a-Suitcase, Panall 8000 all-in-one molecular diagnosis system, and PANA 9600X Automated Nucleic Acid Workstation, as well as a variety of nucleic acid extraction systems and PCR systems, supporting lab detection in automation, informatics, and intelligence.

The nucleic acid extraction and PCR testing reagents cover the detection of various common diseases, meeting the detection needs in clinical diagnosis, epidemic monitoring, food safety, forensic identification, scientific research, etc.

During the event, Tianlong engaged in insights exchanges and cooperative discussions with experts, scholars, as well as companies from around the world, and also presented visitors with pioneering technologies and innovative products, as well as the latest research achievements and application cases in molecular diagnostics.

Thanks to the participation in MEDICA 2023, Tianlong has gained valuable experience and feedback, enhanced market influence, and expanded international cooperation opportunities. In the future, Tianlong will continue to develop research and development efforts and innovations in the medical industry.


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Rapid AKI Test
Acute Kidney Injury (AKI) Array (4-plex)
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.